1A PARP inhibitor: olaparibFAN Li-ping, JIAO Yuan-yuan, LI Ran, GUO Zi-han, ZHANG Yan-hua1321-13252Research progress and development direction of bio-pharmaceutical industry technology innovation alliance networkWANG Qi-qi, MAO Ning-ying1326-13313The research on technological innovation strategy to enhance corporation growth capability in the perspective of patent licensingLI Lin-ke, DENG Fei-fei, YUAN Hong-mei, YANG Shu-jie1332-13384Influence of phospholipid components on the quality of lipid emulsionsSONG Hua-xian, LIN Jin-ping, LIN Jing-wen, HUA Kun, WANG Yan-ju1339-13425Zebrafish used in toxic target organ studies of Chinese herbsZHANG Yong, GUO Sheng-ya, DENG Zhong-ping, LI Chun-qi1343-13476Research progress of toxicity pathways and molecular initiating events in drug-induced liver injuryJING Xiao, WU Chun-qi, WANG Xi-sha, WANG Quan-jun1348-13547Antithrombotic activity of Formononetin sodium and its mechanismWAN Yan-jun, ZHUANG Peng-wei, ZHANG Yan-jun1355-13588Research progress of the dosage form improvement and administration mode of triptolideYU Ya-ting, ZHU Wei-feng, JIN Chen, CHEN Li-hua, GUAN Yong-mei1359-13629Development of antiplatelet agents for thrombotic diseasesHAN Cong-fan, FENG Wen-hua1363-136910An overview of long-acting contraceptives and devicesZENG Jia, QIU Nian-ping, LI Fang, PAN Feng, LIU Dan-ping, FENG Ling-lin1370-137711Component difference between traditional decotion and formula granules decoction of traditional Chinese medicine berberine1378-138412A comprehensive evaluation of the masking effect of traditional Chinese medicine companion based on ISEM and FSEM1385-139013Analysis of complete information static game of the main stakeholders of clinical trialsYANG Fan, WANG Meng-yuan, TAO Tian-tian, YAO Wen-bing, SHAO Rong1391-139514The legal relationship between sponsors and other bodies of drug clinical trialsYANG Fan, TAO Tian-tian, WANG Meng-yuan, YAO Wen-bing, SHAO Rong1396-140015Uncertainty evaluation of determination of vancomycin in human cerebrospinal fluid by HPLCWANG Jia-qing, ZHAO Zhi-gang, MEI Sheng-hui1401-140616Treatment of post-infection irritable bowel with rifaximin combined with lactobacillus complex capsulesJI Meng-chen, CUI Li-hong1407-141217The clinical efficacy of domestic escitalopram tablets on endothelial function and cardiovascular events in chronic ischemia heart failure patients with depressive disorderZHAO Qing-zhen, LIU Gang, LIU Chao1413-141618Design, synthesis and activities of specific urate transporter inhibitors: benzofuran derivatives containing carboxyl groupsDONG Shuai, CHEN Jia-sheng, WU Ting, QIU Yu-chang, CAO Ying, PANG Jian-xin, XI Bao-min1417-142319Formulation, characterization, and pharmacokinetics of solid lipid nanoparticles loaded with naringeninBIAN Long-yan1424-143020Analysis of anti-parkinson disease drugs used in 34 hospitals in Nanjing during 2012-2014LIU Xiao-hua, ZHU Yong-hong1431-1435 